Health Care & Life Sciences » Pharmaceuticals | Proteostasis Therapeutics Inc.

Proteostasis Therapeutics Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
15,720.00
15,772.00
25,040.00
37,232.00
59,432.00
61,832
Depreciation, Depletion & Amortization
608.00
427.00
272.00
306.00
235.00
1,778
Other Funds
456.00
900.00
935.00
1,870.00
3,717.00
3,996
Funds from Operations
14,656.00
14,445.00
23,833.00
35,056.00
55,480.00
56,058
Changes in Working Capital
1,742.00
5,786.00
4,418.00
6,869.00
3,085.00
2,786
Net Operating Cash Flow
12,914.00
8,659.00
19,415.00
41,925.00
52,395.00
58,844
Capital Expenditures
41.00
172.00
263.00
229.00
118.00
Sale of Fixed Assets & Businesses
-
-
-
13.00
-
Purchase/Sale of Investments
-
-
-
66,812.00
20,345.00
Net Investing Cash Flow
41.00
172.00
263.00
67,028.00
20,227.00
Issuance/Reduction of Debt, Net
-
9,921.00
5,000.00
-
-
Net Financing Cash Flow
16.00
15,030.00
24,729.00
113,722.00
43,279.00
Net Change in Cash
12,939.00
6,199.00
5,051.00
4,769.00
11,111.00
Free Cash Flow
12,955.00
8,831.00
19,678.00
42,154.00
52,513.00
Change in Capital Stock
16.00
5,109.00
19,729.00
113,722.00
43,279.00

About Proteostasis Therapeutics

View Profile
Address
80 Guest Street
Boston Massachusetts 02135
United States
Employees -
Website http://www.proteostasis.com
Updated 07/08/2019
Proteostasis Therapeutics, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines intend to treat cystic fibrosis, protein conformational and neurodegenerative diseases. The company was founded by William Balch, Jeffery W.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.